World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
58939
World Ranking
5073
National Ranking
2745

Overview

Scott Kopetz is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine with extensive contributions in oncology and biochemistry, genetics, and molecular biology.

The scientist has published extensively in subfields such as oncology, cancer research, pathology and forensic medicine, molecular biology, and pulmonary and respiratory medicine. Their work covers many topics including colorectal cancer treatments and studies, cancer genomics and diagnostics, genetic factors in colorectal cancer, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, gastric cancer management and outcomes, and cancer treatment and pharmacology.

Notable recent papers include:

  • Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study, 2021, Journal of Clinical Oncology
  • Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406), 2020, Journal of Clinical Oncology
  • ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper, 2020, Nature Reviews Clinical Oncology
  • Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility, 2020, Gut
  • Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142, 2022, Annals of Oncology

Scott Kopetz frequently collaborates with several researchers, including:

  • Michael J. Overman
  • Van K. Morris
  • Kanwal Raghav
  • John Paul Shen
  • Benny Johnson

Their work has appeared in multiple scientific venues, with prominent publications in:

  • Journal of Clinical Oncology
  • Cancer Research
  • Annals of Oncology
  • Clinical Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • The consensus molecular subtypes of colorectal cancer

    Justin Guinney;Rodrigo Dienstmann;Rodrigo Dienstmann;Xingwu Wang;Xingwu Wang;Aurélien De Reyniès

  • Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

    Michael J. Overman;Ray McDermott;Joseph L. Leach;Sara Lonardi

  • Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer

    Michael J. Overman;Sara Lonardi;Ka Yeung Mark Wong;Heinz Josef Lenz

  • Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy

    Scott Kopetz;George J. Chang;Michael J. Overman;Cathy Eng

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

    Scott Kopetz;Axel Grothey;Rona Yaeger;Eric Van Cutsem

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

    Rodrigo Dienstmann;Louis Vermeulen;Justin Guinney;Scott Kopetz

  • Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

    Ben Tran;Scott Kopetz;Jeanne Tie;Peter Gibbs

  • Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

    Scott Kopetz;Jayesh Desai;Emily Chan;Joel Randolph Hecht

  • Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

    Dan G. Blazer;Yoji Kishi;Dipen M. Maru;Scott Kopetz

  • CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

    Hui Ling;Riccardo Spizzo;Yaser Atlasi;Milena Nicoloso

  • Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases

    Yun Shin Chun;Jean Nicolas Vauthey;Piyaporn Boonsirikamchai;Dipen M. Maru

  • Combined BRAF and MEK inhibition with dabrafenib and trametinib in BRAF V600-Mutant colorectal cancer

    Ryan B. Corcoran;Chloe E. Atreya;Gerald S. Falchook;Eunice L. Kwak

  • Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.

    T. Yoshino;D. Arnold;H. Taniguchi;G. Pentheroudakis

  • KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

    Wenting Liao;Michael J. Overman;Adam T. Boutin;Xiaoying Shang

  • Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance.

    Scott Kopetz;Paulo M. Hoff;Jeffrey S. Morris;Robert A. Wolff

  • Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals from 2008 to 2018

    Jonathan M. Loree;Seerat Anand;Arvind Dasari;Joseph M. Unger

  • Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

    Funda Meric-Bernstam;Lauren Brusco;Kenna Shaw;Chacha Horombe

  • High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases: Response-Based Selection and Complete Resection Define Outcome

    Antoine Brouquet;Eddie K. Abdalla;Scott Kopetz;Christopher R. Garrett

Frequent Co-Authors

Michael J. Overman
Michael J. Overman The University of Texas MD Anderson Cancer Center
Cathy Eng
Cathy Eng Vanderbilt University
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Jean Nicolas Vauthey
Jean Nicolas Vauthey The University of Texas MD Anderson Cancer Center
David S. Hong
David S. Hong The University of Texas MD Anderson Cancer Center
Filip Janku
Filip Janku The University of Texas MD Anderson Cancer Center
Russell Broaddus
Russell Broaddus University of North Carolina at Chapel Hill
Sarina Anne Piha-Paul
Sarina Anne Piha-Paul The University of Texas MD Anderson Cancer Center
George J. Chang
George J. Chang The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your healthcare career options beyond traditional medicine? There are several flexible online pathways to consider. For example, direct msn programs online allow individuals without a nursing background to earn a Master of Science in Nursing, often in less time than traditional routes.

If you're looking to become a nurse quickly, some schools offer an easiest bsn program to get into, making the transition into nursing more accessible for those with varying academic backgrounds.

For students who prefer working in the medical field without direct patient care, medical billing and coding is a rapidly growing area. You can find accredited remote programs offering financial aid for medical billing and coding, making these skills attainable and affordable.

In addition, some prospective nurses seek out nursing programs without teas or other standardized exam requirements, streamlining entry into nursing school.

Best Scientists Citing Scott Kopetz

Trending Scientists

Recently Published Articles